Funding Archives

News and Trends 27 Sep 2022

Capagro launches second fund of €200M to support promising European startups

The most promising startups in the European FoodTech and AgTech sectors will be supported by funding from Capagro. The European AgriTech is building on the success of its first fund five years ago and is now launching its second with a fund of €200 million ($193 million). The launch of the new fund, Capagro Agri-Food […]

September 27, 2022 - 4 minutesmins - By Liza Laws

CEO and founder Bjorn Manuel Hegelich aligning laser beams within a laser system at TAU's facility in Austin, Texas.

News and Trends 26 Sep 2022

TAU Systems to build new generation of compact particle accelerators after $15M investment

TAU Systems has raised $15 million in seed investment to bring particle accelerators to a multitude of users by harnessing the latest laser technology to make electrons surf on three-dimensional plasma waves and accelerate them to ultra-high energies. The news is significant as, until now, high-energy particle accelerators have been limited to countries and governmental […]

September 26, 2022 - 2 minutesmins - By Jim Cornall

Cleara Biotech closes $2.5M round for senescence treatment

News and Trends 26 Sep 2022

Surge raises $2.6M in funding for technology and secures exclusive licensing agreement

Surge, a biotech and artificial intelligence innovator that produces technology to decode immune fingerprints, has received $2.6 million in funding. The technology accurately identifies patients at risk before surgery and enables physicians to quickly forecast the risk of postoperative complications. The funding round was co-led by HCVC, a global early-stage fund dedicated to high-potential […]

September 26, 2022 - 4 minutesmins - By Liza Laws

News and Trends 26 Sep 2022

Kupando raises €13M in series A funding round led by Remiges Ventures

A company developing agonists that stimulate immune cells today (September 26) announced it has secured €13 million ($12.6 million) in series A funding. Germany-based Kupando develops TLR/47 that stimulate innate immunity for use in oncology and infectious diseases. Kupando says it will use the funds to complete IND-enabling work and to initiate the clinical development […]

September 26, 2022 - 2 minutesmins - By Liza Laws

News and Trends 26 Sep 2022

Cuba to receive €46.7M to boost biopharma sector

The Central American Bank for Economic Integration (CABEI) has signed the first financing agreement with the Republic of Cuba for the execution of a project to strengthen the Cuban biopharmaceutical industry. On of the goals of the project is to combat COVID-19. The funding is for a total of €46.7 million ($45 million). The initiative, […]

September 26, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 23 Sep 2022

Grant awarded to help bring to market an innovative treatment for bone cancer

A grant has been awarded to look into the feasibility of bringing to market a new therapy to treat osteosarcoma that aids bone regeneration with fewer side-effects. The European Research Council gave the Proof of Concept grant to professor Cristina Canal from the Technical University of Catalunya’s (UPC) department of materials science and engineering who […]

September 23, 2022 - 3 minutesmins - By Liza Laws

News and Trends 22 Sep 2022

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

Rivus Pharmaceuticals Inc. has completed a $132 million series B financing round. It was led by RA Capital Management with participation from Bain Capital Life Sciences, BB Biotech AG and existing investors Longitude Capital, Medicxi and RxCapital. The financing will further support clinical advancement of lead candidate HU6, a first-in-class controlled metabolic accelerator (CMA) designed […]

September 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

National Hemophilia Foundation launches research fund

The National Hemophilia Foundation (NHF) in the U.S. has announced the launch of Pathway to Cures (P2C), a new venture philanthropy investment fund focused on creating transformational impact across all inheritable blood disorders. Investing alongside and partnering with traditional private capital funds and other industry organizations, P2C hopes to spur the development of inheritable blood […]

September 22, 2022 - 4 minutesmins - By Jim Cornall

Optics11 Life receives €5 million in funding for drug development

News and Trends 21 Sep 2022

Quinten Health closes financing round to advance disease modeling platforms

A financing round to advance disease modeling platforms and virtual twins in real world has been closed by Quinten Health. The company that works in real-world data science, artificial intelligence (AI) and machine learning (ML) for precision care, made the announcement today (September 21). The round is part of the Quinten Group’s €14 million ($13.9 […]

September 21, 2022 - 3 minutesmins - By Liza Laws

News and Trends 21 Sep 2022

Novo Nordisk Foundation investing $200M for first quantum computer for life sciences research

The Novo Nordisk Foundation has awarded a grant of $200 million to establish the first full-scale quantum computer for the development of new medicines. The computer will also provide new insights into climate change and the green transition, which is not possible with classical computers today. The computer could be located in a data center, […]

September 21, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 20 Sep 2022

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

In a deal with a potential value of $110 million over the next five years, CytoReason has announced an extension of its multi-year partnership with Pfizer. Pfizer will make a $20 million equity investment under the terms of the agreement which will give the company the right to use CytoReason’s artificial intelligence (AI) technology and […]

September 20, 2022 - 3 minutesmins - By Liza Laws

glioblastoma oncolytic virus transgene 2

News and Trends 20 Sep 2022

Collaboration to develop new glioblastoma combination therapy nets €1.06M

Dutch biotech CimCure B.V., French biotech company Covalab, Amsterdam UMC (The Netherlands) and the University of Zurich (Switzerland), have received a €1.06M ($1.08M) grant from EUREKA Eurostars. With a total budget of €2.24M ($2.28M), including investments from the partners, the project aims to develop a new treatment against glioblastoma. CimCure is the lead coordinator of […]

September 20, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Funding

Capagro launches second fund of €200M to support promising European startups

TAU Systems to build new generation of compact particle accelerators after $15M investment

Surge raises $2.6M in funding for technology and secures exclusive licensing agreement

Kupando raises €13M in series A funding round led by Remiges Ventures

Cuba to receive €46.7M to boost biopharma sector

Grant awarded to help bring to market an innovative treatment for bone cancer

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

National Hemophilia Foundation launches research fund

Quinten Health closes financing round to advance disease modeling platforms

Novo Nordisk Foundation investing $200M for first quantum computer for life sciences research

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

Collaboration to develop new glioblastoma combination therapy nets €1.06M

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!